Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-272529
Filing Date
2022-10-28
Accepted
2022-10-28 16:31:51
Documents
10
Effectiveness Date
2022-10-28

Document Format Files

Seq Description Document Type Size
1 FORM S-8 d305916ds8.htm S-8 53685
2 EX-4.1 d305916dex41.htm EX-4.1 2401
3 EX-5.1 d305916dex51.htm EX-5.1 4483
4 EX-10.2 d305916dex102.htm EX-10.2 23685
5 EX-10.3 d305916dex103.htm EX-10.3 14224
6 EX-10.4 d305916dex104.htm EX-10.4 23102
7 EX-23.1 d305916dex231.htm EX-23.1 1677
8 EX-FILING FEES d305916dexfilingfees.htm EX-FILING FEES 16891
9 GRAPHIC g305916g00j01.jpg GRAPHIC 22694
10 GRAPHIC g305916g00j02.jpg GRAPHIC 32807
  Complete submission text file 0001193125-22-272529.txt   217908
Mailing Address 4560 JINKE ROAD BLDG. 1, 4F, PUDONG SHANGHAI F4 201210
Business Address 4560 JINKE ROAD BLDG. 1, 4F, PUDONG SHANGHAI F4 201210 862161632588
Zai Lab Ltd (Filer) CIK: 0001704292 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-268054 | Film No.: 221342417
SIC: 2834 Pharmaceutical Preparations